MBX Biosciences (MBX) News Today

MBX Biosciences logo
$53.12 -2.82 (-5.04%)
Closing price 04:00 PM Eastern
Extended Trading
$53.12 0.00 (0.00%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is MBX Biosciences Dropping Today?

MBX Biosciences, Inc. (NASDAQ: MBX) has mixed recent news: an analyst’s bullish rating and price target offer support, while an insider share sale and forecasts for continuing losses may weigh on sentiment.

  • Positive Sentiment: HC Wainwright reiterated a Buy rating and set a $90 price target, well above MBX’s recent trading level. Its FY2026 loss estimate of $3.13 per share is also slightly less severe than the cited consensus forecast. Brokers Issue Forecasts for MBX Biosciences FY2026 Earnings
  • Negative Sentiment: Director Steven Hoerter sold 4,893 shares, a transaction investors may view as a modest negative signal. The available report does not specify the sale proceeds. MBX Biosciences Stock: Insider Steven Hoerter Sells 4,893 Shares
  • Negative Sentiment: HC Wainwright’s estimates still project losses, including a $4.37-per-share loss for FY2027—larger than its $3.13-per-share FY2026 forecast. That outlook underscores MBX’s ongoing cash-burning development-stage profile.
Posted 4h agoAI Generated. May Contain Errors.

MBX Biosciences Latest News

Brokers Issue Forecasts for MBX Biosciences FY2026 Earnings
HC Wainwright Forecasts MBX Biosciences FY2026 Earnings
MBX Biosciences (NASDAQ:MBX) Stock: Insider Steven Hoerter Sells 4,893 Shares
MBX Biosciences, Inc. (MBX) Receives a Buy from Oppenheimer
MBX Biosciences, Inc. (MBX) Receives a Buy from Oppenheimer
MBX Biosciences (NASDAQ:MBX) CEO Sells 4,893 Shares of Stock
MBX Biosciences (NASDAQ:MBX) Now Covered by HC Wainwright
MBX Biosciences Expands Board, Appoints New Director
MBX Biosciences, Inc. (MBX) Gets a Buy from Mizuho Securities
MBX Biosciences Names Steve Hoerter Chief Executive

MBX Biosciences Media Mentions By Week

MBX Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MBX
News Sentiment
▼
0.44

0.59
▲
Average
Healthcare
News Sentiment

MBX Biosciences News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MBX Articles
This Week
▼
24

3
▲
MBX Articles
Average Week

MBX Biosciences Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
Page Views
1,455
-8%
Get MBX Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for MBX Biosciences dated 11/16/2026.
From Our Partners